🇺🇸 Omniscan in United States

5,707 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nephrogenic Systemic Fibrosis — 2,220 reports (38.9%)
  2. Pain — 751 reports (13.16%)
  3. Anxiety — 430 reports (7.53%)
  4. Injury — 397 reports (6.96%)
  5. Emotional Distress — 394 reports (6.9%)
  6. Mobility Decreased — 351 reports (6.15%)
  7. Arthralgia — 347 reports (6.08%)
  8. Fibrosis — 275 reports (4.82%)
  9. Skin Hypertrophy — 272 reports (4.77%)
  10. General Physical Health Deterioration — 270 reports (4.73%)

Source database →

Other Other approved in United States

Frequently asked questions

Is Omniscan approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Omniscan in United States?

GE Healthcare is the originator. The local marketing authorisation holder may differ — check the official source linked above.